Manchester score
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
WikiDoc Resources for Manchester score |
|
Articles |
|---|
|
Most recent articles on Manchester score Most cited articles on Manchester score |
|
Media |
|
Powerpoint slides on Manchester score |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Manchester score at Clinical Trials.gov Trial results on Manchester score Clinical Trials on Manchester score at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Manchester score NICE Guidance on Manchester score
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Manchester score Discussion groups on Manchester score Patient Handouts on Manchester score Directions to Hospitals Treating Manchester score Risk calculators and risk factors for Manchester score
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Manchester score |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Manchester score is an indicator of prognosis in small cell lung cancer.[1][2] It is calculated from a number of physical and biochemical markers.
A patient with small cell lung cancer scores one point for each of the following: -
- Serum lactate dehydrogenase exceeds the upper limit of the reference range.
- Serum sodium concentration less than 132 mmol/l.
- Serum alkaline phosphatase over one-and-a-half times the upper limit of the reference range.
- Serum bicarbonate less than 24.
- Karnofsky performance status less than 60.
- Extensive stage disease.
Prognosis
| Manchester score | Prognostic group | Two year survival (%) |
|---|---|---|
| 0-1 | Good | 16.2 |
| 2-3 | Medium | 2.5 |
| 4 or more | Poor | 0 |
References
- ↑ Cerny, T (1987). "Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients". International Journal of Cancer. 39 (2): 146–149. Unknown parameter
|coauthors=ignored (help) - ↑ Kawahara, Masaaki (1996). "Prognostic factors and prognostic staging system for small cell lung cancer". Japanese Journal of Clinical Oncology. Oxford University Press. 27 (3): 158–165. ISSN: 0368-2811. Unknown parameter
|coauthors=ignored (help) - ↑ Maestu, I (Jun 1997). "Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients". Annals of Oncology. 8 (6): 547–553. Unknown parameter
|coauthors=ignored (help)